
Topic
Specialty Pharmacy
Limited distribution, hub services, fulfillment routing, REMS friction, and payer-channel coordination.

Approvals· August 11, 2026 · 20 min read

Specialty· August 10, 2026 · 19 min read
Dermatomyositis Treatment Access (2026): Brepocitinib, Octagam IVIG, and DMARDs

Specialty· August 10, 2026 · 16 min read
Rheumatoid Arthritis Treatment Access (2026): Methotrexate, Biosimilars, and JAKs

Specialty· August 9, 2026 · 17 min read
Alopecia Areata Treatment Access (2026): Litfulo, Leqselvi, and Olumiant

Biosimilars· August 7, 2026 · 14 min read
Osteoporosis access landscape: Prolia's 10 denosumab biosimilars and Evenity
By Ran Chen#Biosimilars#Purple Book#Payer Policy

Specialty· August 6, 2026 · 13 min read
Gout Treatment Access Landscape: Generic ULT to Krystexxa
By Ran Chen#Gout#Krystexxa#allopurinol

Manufacturing· August 5, 2026 · 21 min read
2026 oncology injectable shortage: ifosfamide, carboplatin & buy-and-bill
By Ran Chen#Supply Chain#Oncology#Manufacturing

Deals· August 5, 2026 · 19 min read
Lilly's $3.8B AtaiBeckley deal: big pharma validates psychedelics for TRD
By Ran Chen#M&A#Eli Lilly#Psychedelic Therapy

Specialty· August 4, 2026 · 12 min read
Endometriosis Pain Access: Generics, Orilissa & 24-Month Caps

Specialty· August 4, 2026 · 13 min read
Narcolepsy & Idiopathic Hypersomnia Access: Wakefulness to Oxybates
By Ran Chen#Specialty Pharmacy#REMS#Prior Authorization